NEWS
Our Latest News
ARCHIMED buys Cellese, a pioneering developer of growth factors and exosome-based skincare products
Partnering with existing owners and management, ARCHIMED acquires majority interest in NAMSA, the world leader in medical device testing
September
1,
2020
ARCHIMED raises €1 billion for its MED Platform I Fund
August
28,
2020
ARCHIMED acquires ActiGraph, the fast-growing leader in remote monitoring of mobility and sleep for drug trials
May
18,
2020
368